Redhill Biopharma Ltd (RDHL) Directors and Executive Officers - CSIMarket
CSIMarket
 
Redhill Biopharma Ltd   (NASDAQ: RDHL)

Redhill Biopharma Ltd

Officers & Directors


1. Dror Ben-Asher - Co-Founder, CEO, and Director: Dror Ben-Asher has over 20 years of experience in the pharmaceutical industry. Before founding Redhill, he served as the CEO of NasVax Ltd.

2. Micha Ben Chorin - Co-Founder and Director: Micha Ben Chorin is a seasoned entrepreneur with over 20 years of experience in managing and founding start-ups in the biotech industry.

3. Rick D. Scruggs - Chief Operating Officer: Rick D. Scruggs has over 30 years of experience in the pharmaceutical industry, and he has held leadership positions at several biopharmaceutical companies.

4. Gilead Raday - Chief Financial Officer: Gilead Raday has over 15 years of experience in finance and has held senior finance roles in both private and public biotech companies.

5. Mark L. Levitt - Chief Medical Officer: Mark L. Levitt has over 30 years of experience in the pharmaceutical industry and has led clinical development programs for several approved drugs.

6. Lori Roth - VP of Clinical Operations: Lori Roth has over 20 years of experience in clinical development and operations, and she has held leadership roles at several biotech and pharmaceutical companies.

7. Rely Alon - VP of Business Development and IR: Rely Alon has over 15 years of experience in biotech and healthcare investment banking, business development, and investor relations

Redhill Biopharma Ltd currently has 24 employees.






RDHL Management Effectiveness RDHL Revenue per Employee RDHL Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.